|
Announcements
CELONOVA BIOSCIENCES INC. SELECTS CLINIVATION WORLDVIEW®.
Leading developer of novel medical devices selects clinivation WorldView® as their enterprise solution for on-demand global regulatory intelligence.
Natick, MA, November 19, 2008
- clinivation, Inc. announced today that CeloNova BioSciences Inc. has selected the clinivation WorldView® enterprise solution for On-Demand Global Regulatory Intelligence.
"CeloNova is a one of the world's foremost developers of novel medical devices, and we are pleased that they have chosen clinivation WorldView® for comprehensive, authoritative, and up-to-date global regulatory intelligence," said Richard Morroney, R.A.C., C.Q.A., clinivation's Vice President of Quality and Regulatory Solutions.
About clinivation WorldView® On-Demand Global Regulatory Intelligence
Clinivation WorldView® is the medical device and diagnostic industry's most comprehensive, authoritative, and up-to-date enterprise solution for On-Demand Global Regulatory Intelligence. Providing clear, step-by-step market clearance regulations, processes, and guidance for >99% of the world markets, only clinivation WorldView® delivers tried-and-true intelligence from certified, practicing professionals with real-world experience.
About CeloNova BioSciences
Headquartered in Newnan, Georgia, CeloNova BioSciences creates safe and effective solutions for complex technological and biomedical problems. CeloNova BioSciences develops novel medical devices that are then enhanced by one of the company's proprietary materials, Polyzene ®-F. Polyzene ®-F is highly lubricious, anti-thrombotic, anti-inflammatory, and bacterial-resistant, making it an ideal surface treatment for implanted medical devices. CeloNova's current products include Embozene ™ Color-Advanced Microspheres and the CATANIA ™ Coronary Stent System with NanoThin Polyzene ®-F. For more information, please visit www.celonova.com.
About clinivation, Inc.
Clinivation is the leading provider of integrated solutions that enable global market clearance. Guided by our singular vision - "Excellence in Market Clearance" - clinivation accelerates the entire market clearance cycle to advance new worldwide revenue and achieve new milestones of enterprise value.
Used in over 100,000 product registrations by more than 100 companies worldwide, clinivation's end-to-end technology and services deliver on our vision by eliminating revenue traps from global market clearance operations, increasing process velocity with on-demand regulatory intelligence, automating clearance-driven business controls, simplifying content unification into market clearance applications, aligning quality systems with global market clearance priorities, streamlining clinical development with clearance-focused trials, and enabling management with key performance indicators for continuous improvement and effective governance.
The world's leading medical device, diagnostics, hospital supply, and dental supply companies select clinivation because of our medtech industry focus and our unique, integrated solutions that seamlessly adapt to existing business processes and enterprise infrastructure- without the need to write custom code.
Our core brands include the clinivation Global® xi market clearance platform, clinivation WorldView® on-demand regulatory intelligence, and clinivation Clinical Suite® and clinivation Registry Suite® electronic data capture and clinical data management software.
Founded in 1999, the company is headquartered in Natick, Massachusetts, with regional offices in North America and Asia.
Visit clinivation online at www.clinivation.com
For further information:
For more information on clinivation's integrated solutions that enable global market clearance, please click here or call us at 508.655.6560. |
